| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e6d4d7321e22e3b85d537f2b3f9b1f9b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-065
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
| filingDate |
1999-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6aeeb2b0eed5de335b13959ec64b2f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa30baf0e64baa331289710637bcb97d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_627f0f3ed0cebeadd319c4d2fc8a9f01 |
| publicationDate |
1999-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0955311-A2 |
| titleOfInvention |
Peptide vaccine for canine allergy |
| abstract |
Disclosed is an isolated and purified peptide comprising a leucine positioned two peptide bonds away from a tyrosine-arginine pair, such as having the configuration: leucine-blank-blank-tyrosine-arginine, tyrosine-arginine-blank-blank-leucine, or, leucine-blank-blank-tyrosine-arginine-blank-blank-leucine, where blank is any amino acid. Other peptides of the invention include those with the sequence cysteine-blank-blank-proline-histidine-blank-blank-blank-cysteine; cysteine-blank-proline-histidine-blank-proline-blank-blank-cysteine. The peptides can be linked to a carrier such as a multiply antigen protein or a plant virus particle. Isolated and purified peptides of the invention can be used to induce canine autoantibodies directed to the canine IgE molecule. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0220038-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7931898-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6610297-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0209751-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0220038-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0209751-A3 |
| priorityDate |
1998-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |